CVC-22771-73862
3 vaccinations
1 coded response
36 check-ins
0 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 430 / OH
- Registered
- 2022-10-03
- Relationship
- Child or adolescent in my care
- Guardian
- HPZ-38481-35643
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-03
Registered in v-safe
-
2022-10-03
Dose 1 — Pfizer-BioNTech
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-17
- 2022-10-24
-
2022-10-25
Dose 2 — Pfizer-BioNTech
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-10-29
- 2022-10-30
- 2022-10-31
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
- 2022-11-29
- 2022-12-06
-
2023-01-04
Dose 3 — Pfizer-BioNTech
- 2023-01-05
- 2023-01-06
-
2023-01-07
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2023-01-08
- 2023-01-09
- 2023-01-10
- 2023-01-11
- 2023-01-18
- 2023-01-25
-
2023-02-01
Survey response — day 28, dose 3, under 3MedDRA: Hypersensitivity, Rubber sensitivity, Urticaria — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-02-01
Report sent to call center — day 28, dose 3, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-02-02
-
2023-02-02
Call successfulDoes not wish to fill out VAERS report
- 2023-02-08
- 2023-02-15
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-03 | Pfizer-BioNTech | No |
| 2 | 2022-10-25 | Pfizer-BioNTech | No |
| 3 | 2023-01-04 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypersensitivity | · | · | ✓ |
| SD | Rubber sensitivity | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release